期刊检索 >>

关键字:

风湿病与关节炎

  • 固话:18611675548
  • 地址:北京市朝阳区北四环东路115号院6号楼109室
  • 邮编:100101
  • Email:fsbygjy@163.com
  • 手机:18611675548
  • QQ号:2673938532
  • http://www.fsbygjy.com

您现在的位置:首页-电子期刊-电子期刊

艾拉莫德治疗中重度类风湿关节炎的疗效评价及对骨代谢的影响

来源:http://www.fsbygjy.com 日期:2017/9/1点击量:1089

来源:风湿病与关节炎,2017,6(8:34-37.

 

艾拉莫德治疗中重度类风湿关节炎的疗效评价及对骨代谢的影响(临床研究)

 

马 超,李仿模,陈炜炜

 

  【摘 要目的:探讨艾拉莫德治疗中重度类风湿关节炎患者骨代谢指标的变化。方法:64例中重度类风湿关节炎患者随机分为治疗组和对照组,每组32例。对照组给予常规药物治疗,治疗组给予艾拉莫德治疗。2组1个疗程均为24周。比较2组患者骨代谢指标和疾病活动度指标变化。结果:治疗后,2组血清25羟维生素D3指标比较,差异无统计学意义(t = 1.7121P = 0.0919)。治疗组N-端骨钙素、总Ⅰ型前胶原氨基端延长肽、Ⅰ型胶原降解产物指标明显优于对照组,2组比较,差异有统计学意义(P < 0.05)。2组红细胞沉降率(ESR)、C-反应蛋白、压痛关节数、肿胀关节数指标较治疗前均降低(P < 0.05),且治疗组优于对照组(P < 0.05)。治疗组不良反应发生率34.38%,低于对照组的46.88%结论:艾拉莫德治疗中重度类风湿关节炎患者24周后骨代谢指标明显改善,疾病活动度减低,不良发应发生减少。

  【关键词】 关节炎,类风湿;艾拉莫德;骨代谢指标

 

Efficacy of Iguratimod in the Treatment of Moderate to Severe Rheumatoid Arthritis and Its Effect on Bone Metabolism

MA Chao,LI Fang-mo,CHEN Wei-wei

 

  【ABSTRACTObjective:To investigate the changes of bone metabolism in patients with moderate to severe rheumatoid arthritis treated with Iguratimod.Methods:Sixty-four patients with moderate to severe rheumatoid arthritis were randomly divided into a treatment group and a control group,32 cases in each group.The control group was given conventional medicine,and the treatment group was treated with Iguratimod.The two groups were treated for 24 weeks as a course.The changes of bone metabolism index and disease activity index of the two groups were compared.Results:After treatment,there was no significant difference in serum 25 hydroxy vitamin D3 index between the two groupst = 1.7121,P = 0.0919.The N-MID,Total-PINP and Crosslaps index in the treatment group were significantly better than those in the control group,and the difference between the two groups was statistically significantP < 0.05.The ESR,C-reactive protein,TJC and swelling joint index of the two groups were lower than before treatmentP < 0.05,and the treatment group was better than the control groupP < 0.05.The incidence of adverse reactions in the treatment group was 34.38%,which was lower than that of the control group46.88%).Conclusion:After 24-week treatment with Iguratimod,the bone metabolism index of patients with moderate to severe rheumatoid arthritis has significantly improved,and disease activity and adverse reaction have decreased.

  【Keywordsarthritis,rheumatoid;Iguratimod;bone metabolism index

[上一篇]吲哚美辛联合水调散外敷治疗急性痛风性关节 [下一篇]自拟补肾活血汤联合平乐正骨手法治疗膝骨关

友情链接:

百度 中国科学技术协会 中华中医药学会 中华医学会 中华医学会风湿病分会 中华中医药学会风湿病分会 中国中西医结合学会 中国中西医结合学会风湿病专业委员会 河南风湿网 河南风湿病医院
版权所有:Copyright 2002-2010 风湿病与关节炎 备案:豫ICP备11007478号-1